• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

  • Twitter
  • YouTube
NASBS

NASBS

North American Skull Base Society

  • Home
  • About
    • Mission Statement
    • Bylaws
    • NASBS Board of Directors
    • Committees
      • Committee Interest Form
    • NASBS Policy
    • Donate Now to the NASBS
    • Contact Us
  • Meetings
    • 2027 Annual Meeting
    • Abstracts
      • 2026 Call for Abstracts
      • NASBS Poster Archives
      • 2025 Abstract Awards
    • 2026 Recap
    • NASBS Summer Course
    • Meetings Archive
    • Other Skull Base Surgery Educational Events
  • Resources
    • Member Survey Application
    • NASBS Travel Scholarship Program
    • Research Grants
    • Fellowship Registry
    • The Rhoton Collection
    • Webinars
      • Research Committee Workshop Series
      • ARS/AHNS/NASBS Sinonasal Webinar
      • Surgeon’s Log
      • Advancing Scholarship Series
      • Trials During Turnover: Webinar Series
    • NASBS iCare Pathway Resources
    • Billing & Coding White Paper
  • Membership
    • Join NASBS
    • Membership Directory
    • Multidisciplinary Teams of Distinction
    • NASBS Mentorship Program
  • Fellowship Match
    • NASBS Neurosurgery Skull Base Fellowship Match Programs
    • NASBS Neurosurgery Skull Base Fellowship Match Application
  • Journal
  • Login/Logout

2026 Proffered Presentations

2026 Proffered Presentations

 

← Back to Previous Page

 

S281: ASSOCIATION BETWEEN PITUITARY ADENOMA EXCISION AND RISK OF CEREBROVASCULAR DISEASE IN CUSHING'S DISEASE: A PROPENSITY SCORE MATCHED ANALYSIS
Ryan S Chung, BA; David J Cote, MD, PhD; Robert G Briggs, MD; Ishan Shah, BS; David Gomez, BS; Benjamin Fixman, PhD; Keiko M Kang, MD; Michelle Lin, MD; William Zeng, BS; Jonathan Sisti, MD; John D Carmichael, MD; Gabriel Zada, MD, MS; Keck School of Medicine of USC

Introduction: Cushing’s disease (CD) is a hypercortisolemic condition caused by an ACTH-secreting pituitary adenoma (PA). Cerebrovascular disease (CeVD) represents a particularly severe complication of CD, yet its risk has been only sparsely characterized. This study sought to evaluate the risk of CeVD in patients with CD and to examine how surgical treatment influences this risk.

Methods: We conducted a retrospective, multicenter study using 20 years of data from 69 healthcare organizations in the TriNetX database. Adult patients in the United States with CD were identified and matched 1:1 to non-CD controls using propensity score matching (PSM) for demographics and tobacco use. Risk ratios were calculated to assess the risk of CeVD in CD versus non-CD patients. Among those with CD, we further identified patients who underwent PA excision after diagnosis. Using 1:1 PSM adjusted for demographics and comorbidities (hypertension, diabetes mellitus, and dyslipidemia), we compared CeVD outcomes between patients who did and did not undergo PA excision.

Results: The CD group (n=4,265) was 78.4% female with a mean age at CD diagnosis of 51.1 years. After PSM, CD patients had a significantly higher likelihood of any CeVD (RR=1.97, 95%CI: 1.70-2.29), ischemic stroke (RR=2.35, 95%CI: 1.83-3.01), and hemorrhagic stroke (RR=1.75, 95%CI: 1.22-2.49). Stratification by sex identified similar associations among men and women. 1,377 CD patients who underwent PA excision were identified after matching. PA excision after CD diagnosis was associated with lower risk of any CeVD (RR=0.68, 95%CI: 0.55-0.86, NNT=25.6), ischemic stroke (RR=0.50, 95%CI: 0.35-0.72, NNT=33.3), and mortality (RR=0.52, 95%CI: 0.35-0.77, NNT=40.0) compared to those who did not have excision.

Conclusion: Patients with CD face a significantly elevated risk of CeVD, including both ischemic and hemorrhagic stroke. Surgical excision of the pituitary adenoma may reduce long-term risk of CeVD and overall mortality, underscoring the potential protective role of timely surgical treatment.

 

← Back to Previous Page

Copyright © 2026 North American Skull Base Society · Managed by BSC Management, Inc · All Rights Reserved